Page last updated: 2024-11-10

histrionicotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

histrionicotoxin: toxin isolated from Colombian frog, Dendrobates histrionicus; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

histrionicotoxin : An azaspiro compound that is 1-azaspiro[5.5]undecane substituted by a hydroxy group at position 8, a but-1-en-3-yn-1-yl group at position 7 and a pent-3-en-1-yn-5-yl group at position 2 (the 2S,6R,7S,8S stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6437364
SCHEMBL ID1652672
MeSH IDM0051429

Synonyms (16)

Synonym
histrionicotoxin
34272-51-0
histrionicotoxins
tc29f9m9xw ,
1-azaspiro(5.5)undecan-8-ol, 7-(1z)-1-buten-3-ynyl-2-(2z)-2-penten-4-ynyl-, (2s,6r,7s,8s)-
unii-tc29f9m9xw
1-azaspiro(5.5)undecan-8-ol, 7-(1-buten-3-ynyl)-2-(2-penten-4-ynyl)-, (6r-(6alpha(2s*(z)),7beta(z),8alpha))-
SCHEMBL1652672
histrionicotoxin [mi]
(-)-histrionicotoxin
htx- 283a
(-)-htx
(2s,6r,7s,8s)-7-(1z)-1-buten-3-yn-1-yl-2-(2z)-2-penten-4-yn-1-yl-1-azaspiro(5.5)undecan-8-ol
1-azaspiro(5.5)undecan-8-ol, 7-(1z)-1-buten-3-yn-1-yl-2-(2z)-2-penten-4-yn-1-yl-, (2s,6r,7s,8s)-
DTXSID50897083
(2s,6r,10s,11s)-11-[(z)-but-1-en-3-ynyl]-2-[(z)-pent-2-en-4-ynyl]-1-azaspiro[5.5]undecan-10-ol

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" From the dose-response curve, 50% inhibition of nicotine-evoked striatal dopamine release occurred at 5 microM perhydrohistrionicotoxin, a value similar to that obtained in frog sartorius muscle and Electrophorus electroplax."( The neurotoxin histrionicotoxin interacts with the putative ion channel of the nicotinic acetylcholine receptors in the central nervous system.
Albuquerque, EX; Lunt, GG; Rapier, C; Wonnacott, S, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (60.00)18.7374
1990's6 (12.00)18.2507
2000's6 (12.00)29.6817
2010's7 (14.00)24.3611
2020's1 (2.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (15.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (84.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]